Clinical Peptide & Bioregulator Formulary
At Poly Biotech, we provide access to pharmaceutical-grade peptides, bioregulators, and advanced research compounds designed to support clinical outcomes across metabolic health, recovery, aesthetics, and longevity care.
This catalog is intended as a reference for licensed medical professionals to better understand each molecule’s mechanism, benefits, and common use cases within evidence-informed protocols.
All compounds listed are supplied for professional or research use only—they are not intended for self-administration or over-the-counter sale.
Our goal is to help clinics integrate high-purity formulations confidently and safely, ensuring optimal results for patients under medical supervision.
For questions about wholesale pricing, verification options, or clinic logistics, please contact our support team directly through the form or WhatsApp link on this page.
Category
⚖️ Weight Loss & Metabolic Optimization
Retatrutide
Mechanism of Action: Triple agonist at GLP-1, GIP, and glucagon receptors; increases satiety, energy expenditure, and lipid/glucose metabolism.
Primary Benefits:
- Robust appetite control and calorie reduction
- Improved glycemic control and insulin sensitivity
- Accelerated body-fat loss vs single-agonist approaches
- Useful after plateaus on other incretin agents
Common Pairings / Synergies: 5-Amino-1MQ and NAD+ in comprehensive metabolic programs.
Treatment Focus: ⚖️ Weight Loss · Metabolic Syndrome · 🧬 Longevity
Clinical Insight: Adopted when clinics need next-gen outcomes beyond semaglutide/tirzepatide.
Patient Profile: Adults with obesity/metabolic syndrome requiring aggressive appetite and weight control under medical supervision.
Tirzepatide
Mechanism of Action: Dual GLP-1/GIP agonist; reduces appetite and improves post-prandial insulin response.
Primary Benefits:
- Marked reductions in body weight
- Better post-meal glucose control
- Supports cardiometabolic risk reduction
- Weekly frameworks ease adherence
Common Pairings / Synergies: 5-Amino-1MQ or NAD+ for energy support.
Treatment Focus: ⚖️ Weight Loss · Glycemic Control
Clinical Insight: Frequently a first-line GLP-1/GIP option in metabolic clinics.
Patient Profile: Patients with obesity or insulin resistance benefiting from incretin-based therapy.
Semaglutide
Mechanism of Action: GLP-1 receptor agonist; delays gastric emptying and activates central satiety pathways.
Primary Benefits:
- Consistent appetite reduction and weight loss
- Improved fasting and post-prandial glucose
- High adherence with weekly protocols
- Extensive real-world clinical experience
Common Pairings / Synergies: 5-Amino-1MQ or MOTS-c for metabolic efficiency; NAD+ for anti-fatigue support.
Treatment Focus: ⚖️ Weight Loss · Glycemic Control
Clinical Insight: Anchor therapy in many obesity programs due to the breadth of data.
Patient Profile: Adults pursuing long-term weight management with diet/exercise oversight.
AOD-9604
Mechanism of Action: hGH fragment that selectively promotes lipolysis without GH/IGF-1 activation.
Primary Benefits:
- Targets stored-fat mobilization
- Non-stimulant adjunct to weight programs
- Does not affect blood glucose or growth factors
- Useful in cosmetic and medical weight loss
Common Pairings / Synergies: GLP-1 agents or 5-Amino-1MQ for additive effect.
Treatment Focus: ⚖️ Weight Loss · Body Recomposition
Clinical Insight: Often positioned as a gentler add-on in aesthetic clinics.
Patient Profile: Patients seeking fat-reduction support without stimulants.
5-Amino-1MQ (5AM)
Mechanism of Action: NNMT inhibitor; improves cellular NAD+ economy and promotes fatty-acid oxidation.
Primary Benefits:
- Supports increases in metabolic efficiency
- May improve body composition with lifestyle change
- Synergistic with incretin therapies
- Helps reduce metabolic fatigue
Common Pairings / Synergies: GLP-1/dual/triple agonists and NAD+.
Treatment Focus: ⚖️ Weight Loss · Metabolic Support · 🧬 Longevity
Clinical Insight: Used to overcome plateaus and support energy during weight programs.
Patient Profile: Adults needing metabolic-efficiency support within weight-loss protocols.
MOTS-c
Mechanism of Action: Mitochondrial peptide regulating AMPK pathways; increases glucose utilization and fatty-acid oxidation.
Primary Benefits:
- Improves exercise tolerance and energy
- Supports metabolic flexibility
- May assist fat loss with diet/exercise
- Complements GLP-1 programs
Common Pairings / Synergies: NAD+ for energy; GLP-1 agents for appetite control.
Treatment Focus: ⚖️ Weight Loss · Energy · 🧬 Longevity
Clinical Insight: Valuable where fatigue/low energy reduce program adherence.
Patient Profile: Adults with low vitality and metabolic slowdown.
Cagrilintide / Semaglutide (Blend)
Mechanism of Action: Amylin receptor activation plus GLP-1 agonism for enhanced satiety and glycemic control.
Primary Benefits:
- Stronger fullness signaling vs monotherapy
- Supports lower caloric intake and adherence
- Improves post-prandial glucose handling
- Useful in advanced metabolic clinics
Common Pairings / Synergies: 5-Amino-1MQ or MOTS-c for metabolic flexibility.
Treatment Focus: ⚖️ Weight Loss · Glycemic Control
Clinical Insight: Selected to push outcomes beyond single incretin agents.
Patient Profile: Patients requiring intensive appetite suppression and glycemic support.
Cagrilintide
Mechanism of Action: Amylin analog; slows gastric emptying and potentiates satiety signaling.
Primary Benefits:
- Reduces meal size and frequency
- Complements GLP-1 regimens
- Supports steady weight reduction
- May improve diet adherence
Common Pairings / Synergies: GLP-1 agonists or 5-Amino-1MQ.
Treatment Focus: ⚖️ Weight Loss · Appetite Control
Clinical Insight: Deployed where satiety is a primary barrier to success.
Patient Profile: Adults with persistent overeating or cravings despite counseling.
Mazdutide
Mechanism of Action: Dual GLP-1/glucagon receptor agonist (investigational) targeting metabolic outcomes.
Primary Benefits:
- Promising weight reduction (research)
- Potential lipid-metabolism benefits
- May increase energy expenditure
- For research-focused clinics
Common Pairings / Synergies: Consider alongside Survodutide in research protocols.
Treatment Focus: ⚖️ Weight Loss · Research
Clinical Insight: Reserved for investigational use in qualified centers.
Patient Profile: Research subjects under clinical oversight.
Survodutide
Mechanism of Action: GLP-1/glucagon co-agonist under investigation for potent metabolic effects.
Primary Benefits:
- Enhanced satiety and fat oxidation (investigational)
- Potential dyslipidemia improvements
- NAFLD/NASH research interest
- Not for routine clinical use
Common Pairings / Synergies: Research-protocol pairings as approved.
Treatment Focus: ⚖️ Weight Loss · Research
Clinical Insight: Used only within controlled research frameworks.
Patient Profile: Subjects meeting inclusion criteria in supervised trials.
NAD+
Mechanism of Action: Central redox coenzyme supporting mitochondrial ATP production and sirtuin-mediated DNA repair.
Primary Benefits:
- Improves cellular energy and anti-fatigue
- Supports detox pathways
- Complements weight-loss adherence and recovery
- Common IV/SC adjunct in longevity clinics
Common Pairings / Synergies: 5-Amino-1MQ and MOTS-c; alongside GLP-1 therapies.
Treatment Focus: Energy · ⚖️ Weight Loss · 🧬 Longevity
Clinical Insight: Often included to improve vitality and program adherence.
Patient Profile: Adults with low energy during weight-management or anti-aging care.
Category
💪 Recovery, Healing & Tissue Regeneration
BPC-157
Mechanism of Action: Up-regulates growth factors (e.g., VEGF, TGF-β) to promote angiogenesis, fibroblast migration, and collagen synthesis.
Primary Benefits:
- Accelerates tendon/ligament/muscle repair
- Reduces local inflammation/oxidative stress
- Supports GI mucosal protection
- Shortens post-procedure recovery
Common Pairings / Synergies: TB-500; consider SS-31 for oxidative-stress control.
Treatment Focus: 💪 Recovery · Injury Healing · Inflammation · 🧬 Longevity
Clinical Insight: Widely used in orthopedic and post-surgical protocols.
Patient Profile: Soft-tissue injuries or post-operative healing needs.
TB-500
Mechanism of Action: Thymosin beta peptide that promotes actin polymerization, neovascularization, and reduced fibrosis.
Primary Benefits:
- Improves tissue remodeling and circulation
- Decreases adhesions and scarring
- Speeds recovery of overuse injuries
- Complements BPC-157 in healing stacks
Common Pairings / Synergies: BPC-157; add SS-31 for mitochondrial support.
Treatment Focus: 💪 Recovery · Injury Healing
Clinical Insight: Popular in sports medicine and rehab settings.
Patient Profile: Athletes and post-op patients needing faster regeneration.
GHK-Cu
Mechanism of Action: Copper-binding tripeptide that activates collagen synthesis, ECM remodeling, and angiogenesis.
Primary Benefits:
- Improves skin texture, firmness, and repair
- Supports hair follicle health
- Assists scar and wound care
- Antioxidant/anti-inflammatory benefits
Common Pairings / Synergies: Hyaluronic Acid; Snap-8 for expression lines.
Treatment Focus: ✨ Aesthetic · 💪 Recovery · 🧬 Longevity
Clinical Insight: Mainstay in aesthetic mesotherapy and microneedling.
Patient Profile: Non-invasive rejuvenation or scar improvement.
Thymosin Alpha-1
Mechanism of Action: Enhances T-cell function and balances cytokine response.
Primary Benefits:
- Supports recovery after infections
- Improves immune surveillance
- Useful in immune-fatigue states
- Adjunct in longevity protocols
Common Pairings / Synergies: Thymalin or Vilon for broader immune support.
Treatment Focus: 🛡️ Immune · 💪 Recovery
Clinical Insight: Utilized where immune resilience is a priority.
Patient Profile: Low immune tone or post-infectious fatigue under supervision.
Thymalin
Mechanism of Action: Thymic peptide complex; normalizes immune homeostasis and supports regeneration.
Primary Benefits:
- Supports thymic rejuvenation
- Balances inflammatory signaling
- Complements longevity protocols
- May aid recovery after illness
Common Pairings / Synergies: Thymosin Alpha-1 or Thymogen.
Treatment Focus: 🛡️ Immune · 🧬 Longevity · 💪 Recovery
Clinical Insight: Featured in immune-focused regenerative programs.
Patient Profile: Older adults or those with immune dysregulation.
DSIP
Mechanism of Action: Modulates sleep architecture and neuroendocrine stress response.
Primary Benefits:
- Improves depth and continuity of sleep
- Helps normalize stress hormones
- Supports post-training and post-procedure recovery
- Non-sedative profile
Common Pairings / Synergies: CJC-1295 + Ipamorelin for recovery; NAD+ for daytime energy.
Treatment Focus: 💪 Recovery · Sleep · 🧠 Cognitive
Clinical Insight: Chosen when poor sleep limits recovery outcomes.
Patient Profile: Insomnia/fragmented sleep impacting healing.
SS-31
Mechanism of Action: Mitochondria-targeted antioxidant binding cardiolipin to stabilize electron transport and reduce ROS.
Primary Benefits:
- Reduces oxidative stress during recovery
- Improves cellular energy availability
- May reduce post-exertional malaise
- Complements tissue-healing protocols
Common Pairings / Synergies: BPC-157/TB-500 stacks; NAD+.
Treatment Focus: 💪 Recovery · 🧬 Longevity · Energy
Clinical Insight: Used when oxidative stress slows healing.
Patient Profile: Adults with fatigue, overtraining, or complex recovery needs.
Hyaluronic Acid
Mechanism of Action: High-MW glycosaminoglycan providing hydration and viscoelastic support.
Primary Benefits:
- Improves skin hydration and elasticity
- Lubricates joints and soft tissues
- Adjunct in mesotherapy and aesthetics
- Supports post-procedure comfort
Common Pairings / Synergies: GHK-Cu; Glow70 in facial protocols.
Treatment Focus: ✨ Aesthetic · 💪 Recovery
Clinical Insight: Building block in cosmetic and MSK care.
Patient Profile: Hydration/viscoelastic support for skin or joints.
LL-37
Mechanism of Action: Endogenous cathelicidin with antimicrobial, immunomodulatory, and pro-healing effects.
Primary Benefits:
- Broad antimicrobial activity
- Accelerates wound closure
- Modulates inflammation
- Adjunct in dermatologic recovery
Common Pairings / Synergies: KPV for inflammatory skin protocols.
Treatment Focus: 🛡️ Immune · 💪 Recovery · Dermatology
Clinical Insight: Employed selectively in chronic wound care.
Patient Profile: Hard-to-heal skin lesions under specialist care.
KPV
Mechanism of Action: α-MSH–derived tripeptide with anti-inflammatory signaling in skin and gut tissues.
Primary Benefits:
- Down-regulates inflammatory cascades
- Supports barrier repair
- Adjunct in dermatologic protocols
- GI-soothing potential
Common Pairings / Synergies: LL-37 or GHK-Cu depending on indication.
Treatment Focus: Inflammation · 💪 Recovery · Dermatology
Clinical Insight: Applied in post-inflammatory skin care or gut-support contexts.
Patient Profile: Reactive skin or post-inflammatory issues.
Category
💪 Muscle Growth, Strength & Performance
CJC-1295 (No DAC)
Mechanism of Action: GHRH analog stimulating physiologic GH pulses without prolonged receptor activation.
Primary Benefits:
- Supports lean mass and recovery
- Improves sleep quality in some patients
- Favorable with GHRPs
- Well-tolerated optimization tool
Common Pairings / Synergies: Ipamorelin or Sermorelin.
Treatment Focus: 💪 Muscle · 💪 Recovery · 🧬 Longevity
Clinical Insight: Widely used in anti-aging and performance clinics.
Patient Profile: Age-related GH decline or athletes in recovery blocks.
Ipamorelin
Mechanism of Action: Selective GHRP that stimulates GH release with minimal prolactin/cortisol effects.
Primary Benefits:
- Lean mass and recovery support
- Gentle side-effect profile
- Useful in recomp phases
- Improves sleep/recovery
Common Pairings / Synergies: CJC-1295 (No DAC); NAD+ for energy.
Treatment Focus: 💪 Muscle · 💪 Recovery
Clinical Insight: Favored as a well-tolerated GHRP.
Patient Profile: Adults seeking mild, steady GH-axis support.
GHRP-6
Mechanism of Action: Ghrelin receptor agonist; stimulates GH and appetite.
Primary Benefits:
- Supports GH/IGF-1 axis
- Helpful in weight-gain/rehab phases
- Can aid recovery from catabolic states
- Pairs well with GHRH analogs
Common Pairings / Synergies: CJC-1295 (No DAC) or Sermorelin.
Treatment Focus: 💪 Muscle · 💪 Recovery
Clinical Insight: Selected when appetite stimulation is desirable.
Patient Profile: Patients needing intake support during rehab/growth phases.
Sermorelin
Mechanism of Action: GHRH analog that stimulates endogenous GH via pituitary activation.
Primary Benefits:
- Supports lean mass and fat-loss balance
- May improve sleep/recovery
- Combines well with GHRPs
- Physiologic GH patterns
Common Pairings / Synergies: Ipamorelin or GHRP-6.
Treatment Focus: 💪 Muscle · 💪 Recovery · 🧬 Longevity
Clinical Insight: Alternative to CJC-1295 for GH-axis support.
Patient Profile: Adults in hormone optimization programs.
IGF-1 LR3
Mechanism of Action: Long-acting IGF-1 analog; promotes myogenesis and muscle cell differentiation (research use).
Primary Benefits:
- Supports muscle regeneration in models
- Post-training utility in research
- Investigational recovery adjunct
- Not for general use
Common Pairings / Synergies: GH-axis support in approved research contexts.
Treatment Focus: 💪 Muscle · 🔬 Research
Clinical Insight: Reserved for research institutions.
Patient Profile: Subjects in approved studies.
Teriparatide
Mechanism of Action: Recombinant PTH (1-34); stimulates osteoblast activity and bone formation.
Primary Benefits:
- Improves bone mineral density
- Supports skeletal repair
- Adjunct in fracture-healing contexts
- Clinically established agent
Common Pairings / Synergies: Rehab protocols and nutrition support.
Treatment Focus: Bone Health · 💪 Recovery
Clinical Insight: Used under endocrinology/orthopedic guidance.
Patient Profile: Adults with osteoporosis or complex skeletal repair needs.
Category
🧬 Anti-Aging & Longevity
Epitalon
Mechanism of Action: Pineal peptide; may activate telomerase and normalize melatonin rhythms.
Primary Benefits:
- Supports sleep quality and circadian balance
- Potential telomere-maintenance support
- Immune modulation properties
- Integrates into longevity programs
Common Pairings / Synergies: NAD+, MOTS-c; Thymalin for immune tone.
Treatment Focus: 🧬 Longevity · Sleep · 🛡️ Immune
Clinical Insight: Foundational in many longevity protocols.
Patient Profile: Adults seeking healthy-aging support under physician oversight.
Crystagen
Mechanism of Action: Bioregulator associated with DNA-repair and oxidative-damage protection.
Primary Benefits:
- Supports genomic stability
- Adjunct after radiation/oxidative stress
- Complements mitochondrial support
- Part of advanced anti-aging stacks
Common Pairings / Synergies: SS-31 or NAD+ in specialized programs.
Treatment Focus: 🧬 Longevity · Cellular Protection
Clinical Insight: Used in advanced longevity/rehab clinics.
Patient Profile: Adults needing elevated cellular-defense support.
NAD+ (Longevity)
Mechanism of Action: Sirtuin cofactor/redox mediator supporting mitochondrial function and DNA repair.
Primary Benefits:
- Improves energy and cognitive clarity
- Supports cellular maintenance pathways
- Common IV/SC longevity adjunct
- May aid recovery from stress/burnout
Common Pairings / Synergies: Epitalon, MOTS-c, SS-31.
Treatment Focus: 🧬 Longevity · Energy
Clinical Insight: Backbone in many anti-aging clinics.
Patient Profile: Adults pursuing vitality and healthy aging.
MOTS-c (Longevity)
Mechanism of Action: Activates AMPK and improves metabolic resilience at the mitochondrial level.
Primary Benefits:
- Enhances exercise tolerance
- Supports healthy glucose handling
- Synergistic with NAD+ for energy
- Fits well in longevity stacks
Common Pairings / Synergies: NAD+ and Epitalon.
Treatment Focus: 🧬 Longevity · Energy · Metabolic Health
Clinical Insight: Chosen where energy and stamina are limiting factors.
Patient Profile: Adults with low vitality in longevity plans.
Thymalin (Longevity)
Mechanism of Action: Immune-restorative thymic peptide aiding homeostatic balance.
Primary Benefits:
- Supports immunosenescence countermeasures
- Balances cytokine signaling
- Complements regenerative protocols
- Often cyclical in longevity plans
Common Pairings / Synergies: Thymosin Alpha-1 or Thymogen.
Treatment Focus: 🧬 Longevity · 🛡️ Immune
Clinical Insight: Useful for immune tone in aging populations.
Patient Profile: Older adults focused on resilience and recovery.
Category
🧠 Cognitive Health, Mood & Stress
Selank
Mechanism of Action: Anxiolytic neuropeptide modulating GABAergic/monoaminergic systems without sedation.
Primary Benefits:
- Reduces anxiety; improves calm focus
- Supports cognitive performance under stress
- Non-sedating daytime profile
- Complements sleep/recovery care
Common Pairings / Synergies: Semax; DSIP for sleep architecture.
Treatment Focus: 🧠 Cognitive · Mood · Stress
Clinical Insight: Useful in burnout and high-demand cognitive settings.
Patient Profile: Adults with anxiety-predominant presentations impacting function.
Semax
Mechanism of Action: Heptapeptide with neurotrophic actions; enhances BDNF-related pathways.
Primary Benefits:
- Improves focus, learning, and memory metrics
- Neuroprotective properties in models
- Stress-resilience support
- Daytime cognitive enhancer
Common Pairings / Synergies: Selank; NAD+ for mental energy.
Treatment Focus: 🧠 Cognitive · Neuroprotection
Clinical Insight: Applied in cognitive optimization and recovery clinics.
Patient Profile: Adults seeking performance or recovering cognitive function.
Pinealon
Mechanism of Action: Short peptide bioregulator associated with cortical neuron support and cerebrovascular health.
Primary Benefits:
- Supports memory consolidation
- May aid long-term brain health
- Complements neuroprotective strategies
- Non-sedating profile
Common Pairings / Synergies: Cortagen; NAD+ for energy.
Treatment Focus: 🧠 Cognitive · 🧬 Longevity
Clinical Insight: Used in aging cognition programs.
Patient Profile: Older adults or those with cognitive complaints.
Cortagen
Mechanism of Action: Bioregulator supporting CNS trophism and stress adaptation.
Primary Benefits:
- Balances CNS signaling under stress
- May improve cognitive resilience
- Complements Pinealon in brain stacks
- Useful in longevity neurosupport
Common Pairings / Synergies: Pinealon; Selank/Semax as needed.
Treatment Focus: 🧠 Cognitive · Stress
Clinical Insight: Considered when chronic stress impacts cognition.
Patient Profile: Adults with CNS irritability from prolonged stress.
DSIP (Cognitive/Sleep)
Mechanism of Action: Influences sleep-stage architecture and endocrine stress balance.
Primary Benefits:
- Enhances restorative sleep
- May reduce nighttime awakenings
- Supports next-day recovery/clarity
- Non-habit forming profile
Common Pairings / Synergies: GH-axis support; NAD+ based on clinic design.
Treatment Focus: Sleep · 💪 Recovery · 🧠 Cognitive
Clinical Insight: Selected when sleep fragmentation undermines outcomes.
Patient Profile: Adults with insomnia or poor sleep quality.
Oxytocin (Mood)
Mechanism of Action: Modulates social bonding, trust, and stress reactivity via central pathways.
Primary Benefits:
- May improve social connectedness and mood
- Supports therapeutic engagement
- Fast onset for situational use
- Non-sedative
Common Pairings / Synergies: Behavioral therapy programs.
Treatment Focus: Mood · Stress
Clinical Insight: Applied cautiously in mood/relationship contexts.
Patient Profile: Adults with social anxiety or post-stress malaise under guidance.
Category
♥ Sexual Health & Hormonal Support
PT-141
Mechanism of Action: Central melanocortin receptor agonist enhancing sexual desire/arousal.
Primary Benefits:
- Improves libido in men and women
- Independent of vascular NO pathways
- Useful in performance anxiety
- Adjunct to broader sexual-health care
Common Pairings / Synergies: Oxytocin for mood/bonding.
Treatment Focus: ♥ Sexual Health · Mood
Clinical Insight: Used when desire is the primary limitation.
Patient Profile: Adults with low libido not explained by vascular issues.
Oxytocin (Sexual Health)
Mechanism of Action: Enhances bonding and reduces amygdala-mediated stress responses.
Primary Benefits:
- Supports intimacy and post-encounter well-being
- May reduce performance anxiety
- Complements psychosexual therapy
- Rapid effect profile
Common Pairings / Synergies: PT-141 where appropriate.
Treatment Focus: ♥ Sexual Health · Mood
Clinical Insight: Adjunct in sexual-wellness programs.
Patient Profile: Adults seeking enhanced intimacy and stress reduction.
hCG
Mechanism of Action: LH analog; stimulates Leydig cells for testosterone; maintains spermatogenesis.
Primary Benefits:
- Preserves testicular function during TRT
- Supports fertility parameters
- Useful in PCT frameworks
- Clinically established urologic tool
Common Pairings / Synergies: With GH-axis agents depending on program goals.
Treatment Focus: Hormone Support · Fertility
Clinical Insight: Applied in men’s health and TRT-adjacent care.
Patient Profile: Adult males on TRT or with fertility objectives.
Testagen
Mechanism of Action: Male reproductive bioregulator supporting testicular/accessory gland function.
Primary Benefits:
- Supports hormonal balance
- Adjunct in fertility optimization
- Non-androgenic supportive profile
- Complements broader men’s-health plans
Common Pairings / Synergies: hCG per clinical design.
Treatment Focus: Hormone Support · Fertility
Clinical Insight: Supportive bioregulator in men’s clinics.
Patient Profile: Men seeking reproductive-health support.
Category
✨ Skin, Aesthetics & Cosmetic Medicine
GHK-Cu
Mechanism of Action: Copper peptide driving collagen/elastin; ECM remodeling; angiogenesis.
Primary Benefits:
- Texture, firmness, and repair
- Hair-follicle support
- Scar and wound-care adjunct
- Antioxidant/anti-inflammatory
Common Pairings / Synergies: Hyaluronic Acid; Snap-8 for dynamic lines.
Treatment Focus: ✨ Aesthetic · 💪 Recovery · 🧬 Longevity
Clinical Insight: Mesotherapy/microneedling mainstay.
Patient Profile: Non-surgical rejuvenation and scar improvement.
Glow70
Mechanism of Action: Cosmetic peptide blend promoting dermal rejuvenation and hydration pathways.
Primary Benefits:
- Improves tone, glow, and elasticity
- Complements microneedling/mesotherapy
- Adjunct in post-procedure recovery
- Non-invasive enhancement
Common Pairings / Synergies: Hyaluronic Acid or GHK-Cu.
Treatment Focus: ✨ Aesthetic · 💪 Recovery
Clinical Insight: Popular in facial rejuvenation programs.
Patient Profile: Adults seeking non-surgical skin improvement.
Snap-8
Mechanism of Action: Topical octapeptide interfering with SNARE complex involved in expression lines.
Primary Benefits:
- Softens dynamic wrinkles (non-invasive)
- Adjunct or alternative to neuromodulators
- Pairs with GHK-Cu for texture
- Well-tolerated topical profile
Common Pairings / Synergies: GHK-Cu or Hyaluronic Acid.
Treatment Focus: ✨ Aesthetic
Clinical Insight: Used in topical anti-aging protocols.
Patient Profile: Adults seeking mild, non-injectable line reduction.
Hyaluronic Acid (Aesthetic)
Mechanism of Action: Hydrophilic polymer retaining water to improve dermal volume and lubrication.
Primary Benefits:
- Hydration and plumpness
- Comfort post-procedure
- Adjunct to GHK-Cu for texture
- Barrier-function support
Common Pairings / Synergies: Glow70 and GHK-Cu.
Treatment Focus: ✨ Aesthetic · 💪 Recovery
Clinical Insight: Clinic staple for hydration-centric protocols.
Patient Profile: Dehydrated or photoaged skin.
Botulinum Toxin Type A (100 IU)
Mechanism of Action: Inhibits acetylcholine release at NMJ; relaxes dynamic wrinkles.
Primary Benefits:
- Standard of care for expression lines
- Precise aesthetic sculpting
- Adjunct to topical peptide regimens
- Durable outcomes
Common Pairings / Synergies: Snap-8 / GHK-Cu in comprehensive plans.
Treatment Focus: ✨ Aesthetic
Clinical Insight: Core offering in aesthetic medicine.
Patient Profile: Adults seeking dynamic line reduction under qualified providers.
Lemon Bottle
Mechanism of Action: Aesthetic solution used by practitioners for localized cosmetic contouring within professional protocols.
Primary Benefits:
- Used in targeted cosmetic procedures
- Complements non-surgical approaches
- Applied by trained professionals
- Adjunct to lifestyle/aesthetic plans
Common Pairings / Synergies: Hyaluronic Acid or GHK-Cu per clinic design.
Treatment Focus: ✨ Aesthetic
Clinical Insight: Used selectively by experienced practitioners.
Patient Profile: Adults pursuing professional cosmetic contouring.
Category
🛡️ Immune Function & Inflammation Control
Thymosin Alpha-1
Mechanism of Action: Enhances T-cell activity; balances cytokine response.
Primary Benefits:
- Immune resilience after infections
- Improves immune surveillance
- Useful in immune-fatigue states
- Longevity adjunct
Common Pairings / Synergies: Thymalin or Vilon.
Treatment Focus: 🛡️ Immune · 💪 Recovery
Clinical Insight: Where immune recovery is prioritized.
Patient Profile: Adults with low immune tone or post-infectious fatigue.
Thymalin
Mechanism of Action: Thymic peptide aiding immune homeostasis and regeneration.
Primary Benefits:
- Balances immune signaling
- Resilience in chronic dysregulation
- Longevity integration
- Recovery support
Common Pairings / Synergies: Thymosin Alpha-1 or Thymogen.
Treatment Focus: 🛡️ Immune · 🧬 Longevity
Clinical Insight: Used in regenerative immune programs.
Patient Profile: Immune dysregulation or aging-related decline.
Vilon
Mechanism of Action: Short thymic peptide with broad immunomodulatory effects.
Primary Benefits:
- Balances inflammatory signaling
- Supports immune tone
- Adjunct in regenerative programs
- Non-stimulatory profile
Common Pairings / Synergies: Thymalin or Thymogen.
Treatment Focus: 🛡️ Immune · Inflammation
Clinical Insight: Used when balance (not stimulation) is desired.
Patient Profile: Adults with chronic low-grade inflammation under supervision.
LL-37 (Immune)
Mechanism of Action: Endogenous antimicrobial bridging innate immunity and wound repair.
Primary Benefits:
- Broad antimicrobial activity
- Supports wound closure
- Modulates inflammation
- Dermatologic utility
Common Pairings / Synergies: KPV in skin protocols.
Treatment Focus: 🛡️ Immune · Dermatology
Clinical Insight: Cautious use in specialist settings.
Patient Profile: Chronic skin-integrity challenges.
KPV (Immune)
Mechanism of Action: Anti-inflammatory tripeptide via melanocortin pathways.
Primary Benefits:
- Down-regulates pro-inflammatory mediators
- Soothes reactive tissues
- Adjunct in skin/gut support
- Pairs well in recovery plans
Common Pairings / Synergies: LL-37 or GHK-Cu as indicated.
Treatment Focus: 🛡️ Immune · Inflammation · Dermatology
Clinical Insight: Helpful add-on in post-inflammatory cases.
Patient Profile: Sensitive/reactive skin or GI irritation.
Category
🧩 Organ-Specific Bioregulators
Prostamax
Mechanism of Action: Prostate-targeted short peptide bioregulator supporting glandular homeostasis.
Primary Benefits:
- Supports urinary-flow balance
- Adjunct in men’s-health programs
- Non-hormonal supportive profile
- Complements lifestyle measures
Common Pairings / Synergies: Testagen where appropriate.
Treatment Focus: Urology · Men’s Health
Clinical Insight: Supportive measure in prostate-health plans.
Patient Profile: Adult men seeking non-hormonal prostate support.
Ovagen
Mechanism of Action: Hepatic bioregulator associated with liver tissue maintenance and detox support.
Primary Benefits:
- Hepatocellular resilience
- Adjunct in metabolic care
- Complements lifestyle detoxification
- Non-stimulant profile
Common Pairings / Synergies: Livagen in liver-focused stacks.
Treatment Focus: Liver · Detox · Metabolic
Clinical Insight: Used for supportive hepatic care.
Patient Profile: Adults seeking gentle liver support under guidance.
Livagen
Mechanism of Action: Liver bioregulator associated with hepatic regeneration signaling.
Primary Benefits:
- Assists hepatic recovery frameworks
- Supports enzymatic balance
- Works with diet/lifestyle change
- Non-pharmacologic support
Common Pairings / Synergies: Ovagen; Pancragen for metabolic synergy.
Treatment Focus: Liver · Detox
Clinical Insight: Supportive hepatic protocols.
Patient Profile: Adults with lifestyle-related liver stress (clinician-supervised).
Vesugen
Mechanism of Action: Vascular/endothelial bioregulator supporting arterial elasticity and microcirculation.
Primary Benefits:
- Promotes endothelial function
- Adjunct in circulatory support
- Complements cardiometabolic care
- Non-hemodynamic support
Common Pairings / Synergies: Cardiogen in cardiovascular stacks.
Treatment Focus: Cardiovascular · Circulation
Clinical Insight: Supportive vascular-health programs.
Patient Profile: Adults concerned with microcirculation/vascular tone.
Cardiogen
Mechanism of Action: Cardiac bioregulator associated with myocardial metabolic support.
Primary Benefits:
- Supports cardiac tissue resilience
- Adjunct in recovery frameworks
- Complements circulation support
- Integrates with lifestyle care
Common Pairings / Synergies: Vesugen as indicated.
Treatment Focus: Cardiovascular · 💪 Recovery
Clinical Insight: Supportive role in cardiometabolic programs.
Patient Profile: Adults seeking adjunct cardiac support under guidance.
Pancragen
Mechanism of Action: Pancreatic bioregulator associated with exocrine/endocrine balance.
Primary Benefits:
- Supports metabolic homeostasis
- Adjunct in glycemic support plans
- Non-stimulant background support
- Pairs with diet/exercise
Common Pairings / Synergies: May accompany GLP-1 programs when appropriate.
Treatment Focus: Metabolic · Glycemic Support
Clinical Insight: Supportive metabolic care.
Patient Profile: Adults under supervision for glucose regulation.
Bronchogen
Mechanism of Action: Respiratory bioregulator supporting bronchial tissue health and repair.
Primary Benefits:
- Adjunct in post-infection recovery
- May support airway-lining integrity
- Complements pulmonary rehab
- Non-bronchodilator supportive role
Common Pairings / Synergies: Chonluten for broader respiratory support.
Treatment Focus: Respiratory · 💪 Recovery
Clinical Insight: After respiratory illness recovery.
Patient Profile: Adults with residual airway irritation under supervision.
Chonluten
Mechanism of Action: Lung tissue bioregulator associated with alveolar/bronchial support.
Primary Benefits:
- Pulmonary tissue resilience
- Adjunct during recovery phases
- Complements respiratory hygiene
- Non-stimulant supportive role
Common Pairings / Synergies: Bronchogen where appropriate.
Treatment Focus: Respiratory · 💪 Recovery
Clinical Insight: Used in pulmonary-recovery stacks.
Patient Profile: Adults in lung-tissue recovery programs.
Cartalax
Mechanism of Action: Joint-cartilage bioregulator supporting matrix homeostasis.
Primary Benefits:
- Adjunct in degenerative joint care
- May complement rehab outcomes
- Pairs with HA for comfort
- Non-NSAID supportive profile
Common Pairings / Synergies: Hyaluronic Acid and BPC-157/TB-500 (context-dependent).
Treatment Focus: Musculoskeletal · Joint Support
Clinical Insight: MSK/orthopedic longevity care.
Patient Profile: Adults with joint wear seeking supportive measures.
Vesilute
Mechanism of Action: Renal bioregulator associated with nephron support and filtration balance.
Primary Benefits:
- Adjunct in kidney-support plans
- Non-stimulant supportive profile
- Complements hydration and diet
- Part of detox frameworks
Common Pairings / Synergies: Often used with liver bioregulators when indicated.
Treatment Focus: Renal · Detox
Clinical Insight: Supportive role in renal wellness programs.
Patient Profile: Adults needing gentle kidney support under supervision.
Testagen (Bioregulator)
Mechanism of Action: Male reproductive bioregulator supporting spermatogenic tissue signaling.
Primary Benefits:
- Adjunct in fertility support
- Non-androgenic supportive role
- Complements TRT-adjacent care
- Pairs with lifestyle measures
Common Pairings / Synergies: hCG or Prostamax as appropriate.
Treatment Focus: Fertility · Hormone Support
Clinical Insight: Supportive measure by men’s health clinics.
Patient Profile: Men with reproductive goals under clinician guidance.
Category
🔬 Experimental & Research Molecules
Adamax (984 Da)
Mechanism of Action: Investigational small molecule explored for cellular repair and energy modulation.
Primary Benefits:
- Research-only applications
- Adjunct in experimental protocols
- Not for general consumer use
- Institutional oversight required
Common Pairings / Synergies: Pairs as allowed by protocol in research settings.
Treatment Focus: Research
Clinical Insight: Provided to qualified research practitioners.
Patient Profile: Subjects meeting criteria in controlled studies.
Adamax (1032 Da)
Mechanism of Action: Higher-mass variant under investigation for similar cellular support pathways.
Primary Benefits:
- Research-only applications
- Adjunct in experimental protocols
- Not for general consumer use
- Institutional oversight required
Common Pairings / Synergies: As permitted in protocol-driven use.
Treatment Focus: Research
Clinical Insight: Reserved for research environments.
Patient Profile: Subjects within supervised studies.
SLU-PP-332
Mechanism of Action: Novel research compound under evaluation for metabolic modulation and energy expenditure.
Primary Benefits:
- Experimental metabolic applications
- Potential synergy with lifestyle interventions
- Not established for clinical use
- Research oversight mandatory
Common Pairings / Synergies: Protocol-dependent combinations only.
Treatment Focus: Research · Metabolic
Clinical Insight: Used strictly within investigational frameworks.
Patient Profile: Suitable research subjects only.
Pnc-27
Mechanism of Action: Investigational peptide studied for selective interaction with aberrant cell membranes.
Primary Benefits:
- Laboratory research contexts
- Not approved for routine clinical use
- Specialist oversight needed
- Handled under research SOPs
Common Pairings / Synergies: Protocol-specific pairings only.
Treatment Focus: Research
Clinical Insight: Restricted to qualified labs/clinics.
Patient Profile: Subjects in approved investigational protocols.
Dermorphin
Mechanism of Action: Potent opioid-like peptide under research for analgesic properties.
Primary Benefits:
- Experimental pain-modulation studies
- Not for routine clinical use
- Strict handling requirements
- Specialist oversight
Common Pairings / Synergies: Protocol-specific combinations only.
Treatment Focus: Research · Analgesia
Clinical Insight: Limited to research contexts.
Patient Profile: Approved research subjects only.
Fragment 176–191
Mechanism of Action: HGH fragment targeting lipolysis pathways without full GH axis effects.
Primary Benefits:
- Investigational support for fat mobilization
- Adjunct in body composition research
- Non-stimulant profile
- Not a substitute for GH
Common Pairings / Synergies: May be combined in research with metabolic agents as approved.
Treatment Focus: Research · Metabolic
Clinical Insight: Used by research-oriented clinics.
Patient Profile: Subjects in body composition studies.
Melanotan I
Mechanism of Action: Synthetic analog of α-MSH acting at melanocortin receptors to increase melanogenesis.
Primary Benefits:
- Pigmentation enhancement under supervision
- Adjunct in photoprotection research
- Aesthetic research interest
- Not for unsupervised use
Common Pairings / Synergies: GHK-Cu for skin care plans as permitted.
Treatment Focus: Aesthetic · Research
Clinical Insight: Used in niche research/aesthetic contexts.
Patient Profile: Adults in supervised pigmentation programs.
GHRP-2
Mechanism of Action: Ghrelin receptor agonist stimulating GH release; more potent appetite effect than some GHRPs.
Primary Benefits:
- GH axis support in research settings
- May aid catabolic recovery contexts
- Pairs with GHRH analogs
- Stronger orexigenic profile
Common Pairings / Synergies: CJC-1295/Sermorelin in research protocols.
Treatment Focus: 💪 Muscle · 💪 Recovery · 🔬 Research
Clinical Insight: Used selectively due to appetite effects.
Patient Profile: Subjects needing intake support under supervision.
Tesamorelin
Mechanism of Action: GHRH analog with clinical use in specific lipodystrophy contexts; stimulates endogenous GH.
Primary Benefits:
- Reduces visceral adipose tissue in studied populations
- Supports GH axis with defined indications
- Data-backed in select groups
- Monitor per guidelines
Common Pairings / Synergies: Exercise/nutrition plans.
Treatment Focus: Metabolic · GH Axis
Clinical Insight: Used under defined indications and protocols.
Patient Profile: Adults meeting clinical criteria.
FoxO4-DRI (FOXO4)
Mechanism of Action: Peptide designed to disrupt FOXO4-p53 interaction, promoting senescent cell apoptosis (senolytic concept).
Primary Benefits:
- Investigational senolytic approach
- Potential tissue rejuvenation research
- Not approved for clinical use
- Specialist oversight required
Common Pairings / Synergies: Research-only pairings per protocol.
Treatment Focus: Research · Longevity
Clinical Insight: Restricted to experimental settings.
Patient Profile: Subjects in senescence research.
Abaloparatide
Mechanism of Action: PTHrP analog stimulating osteoblast activity and bone formation.
Primary Benefits:
- Established efficacy in osteoporosis treatment
- Improves bone density metrics
- Alternative to teriparatide
- Monitored under specialist care
Common Pairings / Synergies: Rehab and nutrition programs.
Treatment Focus: Bone Health
Clinical Insight: Used under endocrinology guidance.
Patient Profile: Adults with high fracture risk profiles.
ARA-290 (Cibinetide)
Mechanism of Action: Non-hematopoietic EPO-derived peptide activating EPOR/CD131 for cytoprotective anti-inflammatory signaling.
Primary Benefits:
- Investigated in neuropathic pain and inflammation
- Potential tissue protection benefits
- Well-tolerated in studies
- Not widely approved for routine use
Common Pairings / Synergies: Recovery agents per protocol.
Treatment Focus: 💪 Recovery · Inflammation · 🔬 Research
Clinical Insight: Used in specialized clinics with research orientation.
Patient Profile: Subjects with neuropathic features in studies.
Glutathione
Mechanism of Action: Tripeptide antioxidant central to redox balance and detoxification via GSH-dependent enzymes.
Primary Benefits:
- Supports hepatic detox pathways
- Reduces oxidative burden
- Adjunct in skin brightening protocols
- Common IV therapy in wellness clinics
Common Pairings / Synergies: NAD+ and Vitamin C based on protocol.
Treatment Focus: Detox · Antioxidant · ✨ Aesthetic
Clinical Insight: Foundational antioxidant in many IV suites.
Patient Profile: Adults seeking redox support under supervision.
Hexarelin
Mechanism of Action: Potent GHRP with strong GH-releasing activity via GHS-R1a.
Primary Benefits:
- Robust GH axis stimulation
- Useful in short research cycles
- May impact lipids/GH markers
- Requires careful oversight
Common Pairings / Synergies: GHRH analogs per research design.
Treatment Focus: 💪 Muscle · 🔬 Research
Clinical Insight: Used in limited, supervised research contexts.
Patient Profile: Subjects in GH-axis studies.
L-Carnitine (Injectable)
Mechanism of Action: Facilitates mitochondrial shuttling of long-chain fatty acids for β-oxidation.
Primary Benefits:
- Supports energy and endurance
- Adjunct in metabolic and weight programs
- Useful in athletes under guidance
- Favorable safety profile when supervised
Common Pairings / Synergies: MOTS-c or NAD+ for energy; GLP-1 agents for fat loss programs.
Treatment Focus: Energy · Metabolic · Performance
Clinical Insight: Common adjunct in performance/metabolic clinics.
Patient Profile: Adults needing energy/fat-oxidation support.
CJC-1295 / Ipamorelin (Blend)
Mechanism of Action: Combines GHRH and GHRP mechanisms to mimic physiologic GH pulses.
Primary Benefits:
- Improves sleep, recovery, and body composition
- Lean mass support
- Synergistic GH axis stimulation
- Clinic-friendly tolerance profile
Common Pairings / Synergies: Standalone or with NAD+ for energy; add DSIP for sleep.
Treatment Focus: 💪 Muscle · 💪 Recovery · 🧬 Longevity
Clinical Insight: Signature anti-aging/fitness stack in many clinics.
Patient Profile: Adults seeking balanced GH-axis support.
Cyanocobalamin (Vitamin B12)
Mechanism of Action: Synthetic B12 form essential for methylation, hematologic health, and neurologic function.
Primary Benefits:
- Corrects or prevents B12 deficiency
- Supports energy and cognition
- Adjunct in anemia management
- Well established in clinical practice
Common Pairings / Synergies: Often combined with folate/complex B vitamins in IV/IM suites.
Treatment Focus: Energy · Hematology · Neurology
Clinical Insight: Routine in wellness/primary-care settings.
Patient Profile: Adults with deficiency risk or increased demand.
Category
🧰 Additional Catalog Entries & Clinic Logistics
VIP (Vasoactive Intestinal Peptide)
Mechanism of Action: Neuropeptide that modulates smooth muscle tone, bronchodilation, and anti-inflammatory pathways.
Primary Benefits:
- Adjunct in inflammatory airway contexts (specialist use)
- Neuroprotective/anti-inflammatory interest
- Applied in select fatigue/inflammation cases
- Special handling considerations
Common Pairings / Synergies: Combine with immune or recovery agents per specialist guidance.
Treatment Focus: Respiratory · Inflammation · Neuro
Clinical Insight: Used in niche clinics with experience in VIP protocols.
Patient Profile: Adults under specialist supervision for inflammation/respiratory issues.
Oxytocin (General)
Mechanism of Action: Endogenous peptide modulating social bonding and stress response via central pathways.
Primary Benefits:
- Mood and connection support
- Adjunct in stress reduction
- May improve therapeutic engagement
- Rapid situational benefits
Common Pairings / Synergies: PT-141 (sexual health) or therapy programs.
Treatment Focus: Mood · Sexual Health
Clinical Insight: Applied situationally under clinician direction.
Patient Profile: Adults with stress-linked social or intimacy concerns.
BAC Water (Bacteriostatic Water)
Mechanism of Action: Sterile water with benzyl alcohol preservative; diluent for multi-use reconstitution (logistics supply).
Primary Benefits:
- Supports multi-dose reconstitution workflows
- Reduces contamination risk in clinic settings
- Improves operational efficiency
- Non-therapeutic supply item
Common Pairings / Synergies: Used with lyophilized peptides as directed by clinic SOPs.
Treatment Focus: Clinic Logistics
Clinical Insight: Stocked as a standard reconstitution supply.
Patient Profile: Clinics requiring multi-use sterile diluent per protocol.